HOME
ABOUT
VISION
INVESTMENT CRITERIA
PEOPLE
TEAM
ADVISORY BOARD
PORTFOLIO
CHAMPEL AT A GLANCE
CHAMPEL COMPANIES
Champel Capital LP
Champel Capital Impact Deep Tech Fund LP
THE FUND
BLOG
CONTACT US
Menu
HOME
ABOUT
VISION
INVESTMENT CRITERIA
PEOPLE
TEAM
ADVISORY BOARD
PORTFOLIO
CHAMPEL AT A GLANCE
CHAMPEL COMPANIES
Champel Capital LP
Champel Capital Impact Deep Tech Fund LP
THE FUND
BLOG
CONTACT US
Champel Capital LP
A revolutionary platform unblinding early stage lung cancer diagnostics and treatment.
Medical device
Founded in 2014
Dorian Averbuch - CEO
Ramat Hasharon, Israel
Product launch
22 employees employees
Over 10 Patents
www.bodyvisionmedical.com